Cohance Life

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE03QK01018
NSEID: COHANCE
BSEID: 543064
View on NSE | View on BSE

INR

306.15

9.85 (3.32%)

BSENSE

Mar 25

BSE+NSE Vol: 7.0 lacs

{
  "main_header": {
    "sid": 1003386,
    "name": "Cohance Life",
    "stock_name": "Cohance Life",
    "full_name": "Cohance Lifesciences Ltd",
    "name_url": "stocks-analysis/cohance-life",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "306.15",
    "chg": 9.85,
    "chgp": "3.32%",
    "dir": 1,
    "prev_price": "296.30",
    "mcapval": "11,724.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543064,
    "symbol": "COHANCE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE03QK01018",
    "curr_date": "Mar 25",
    "curr_time": "",
    "bse_nse_vol": "7.0 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 25, 2026",
    "traded_date_str": "2026 03 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/cohance-life-1003386-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Cohance Lifesciences Ltd Valuation Shifts Amidst Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-valuation-shifts-amidst-sector-challenges-3909116",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CohanceLifescie_valuationdot_3909116.png",
        "date": "2026-03-24 08:02:07",
        "description": "Cohance Lifesciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid challenging sector dynamics and a significant divergence from peer valuations. Despite a modest day gain of 0.58%, the stock’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now suggest a more tempered outlook for investors."
      },
      {
        "title": "Cohance Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/cohance-lifesciences-ltd-is-rated-sell-3902695",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CohanceLifescie_mojoScore_3902695.png",
        "date": "2026-03-20 10:10:45",
        "description": "Cohance Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 March 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Cohance Lifesciences Ltd Valuation Shifts Amidst Challenging Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-valuation-shifts-amidst-challenging-market-performance-3897962",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CohanceLifescie_valuationdot_3897962.png",
        "date": "2026-03-18 08:01:13",
        "description": "Cohance Lifesciences Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade as of early 2026. Despite a modest day gain of 2.63%, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now reflect a more tempered market enthusiasm compared to its historical highs and peer benchmarks within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Cohance Lifesciences Ltd Stock Falls to 52-Week Low of Rs.267.85",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-stock-falls-to-52-week-low-of-rs26785-3880281",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CohanceLifescie_priceRelatedfactors_3880281.png",
        "date": "2026-03-09 13:51:15",
        "description": "Cohance Lifesciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.267.85 today, marking a significant decline amid broader market pressures and company-specific performance issues."
      },
      {
        "title": "Cohance Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/cohance-lifesciences-ltd-is-rated-sell-3878616",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CohanceLifescie_mojoScore_3878616.png",
        "date": "2026-03-09 10:10:56",
        "description": "Cohance Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Cohance Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/cohance-lifesciences-ltd-is-rated-sell-3878614",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CohanceLifescie_mojoScore_3878614.png",
        "date": "2026-03-08 10:10:38",
        "description": "Cohance Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 09 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Cohance Lifesciences Declines 9.39%: 5 Key Factors Behind the 52-Week Lows",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-declines-939-5-key-factors-behind-the-52-week-lows-3878153",
        "imagepath": "",
        "date": "2026-03-07 12:06:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Mar:</strong> New 52-week low at Rs.298</p>\n                    <p><strong>4 Mar:</strong> Further 52-week low at Rs.296.5</p>\n                    <p><strong>5 Mar:</strong> Continued decline to Rs.289.35 with valuation upgrade</p>\n                    <p><strong>6 Mar:</strong> Week closes at fresh 52-week low Rs.281.25</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.303.70</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.279.75</div><div class=\"stat-change negative\">-9.39%</div><..."
      },
      {
        "title": "Cohance Lifesciences Ltd Stock Hits 52-Week Low at Rs.281.25",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-stock-hits-52-week-low-at-rs28125-3875828",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CohanceLifescie_priceRelatedfactors_3875828.png",
        "date": "2026-03-06 10:32:48",
        "description": "Cohance Lifesciences Ltd’s stock touched a fresh 52-week low of Rs.281.25 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial performance and market sentiment."
      },
      {
        "title": "Cohance Lifesciences Ltd Falls to 52-Week Low Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-falls-to-52-week-low-amid-continued-downtrend-3873439",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CohanceLifescie_priceRelatedfactors_3873439.png",
        "date": "2026-03-05 10:20:32",
        "description": "Cohance Lifesciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.289.35 today, marking a significant milestone in its ongoing price decline. The stock has underperformed both its sector and the broader market, reflecting persistent pressures on its financial and operational metrics."
      }
    ],
    "total": 530,
    "sid": "1003386",
    "stock_news_url": "https://www.marketsmojo.com/news/cohance-lifesciences-1003386"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Cohance Lifesciences Ltd has declared <strong>100%</strong> dividend, ex-date: 09 Sep 22",
          "dt": "2022-09-09",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Cohance Lifesciences Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 25 Sep 20",
          "dt": "2020-09-25",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Cohance Lifesciences Ltd Valuation Shifts Amidst Sector Challenges

2026-03-24 08:02:07

Cohance Lifesciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid challenging sector dynamics and a significant divergence from peer valuations. Despite a modest day gain of 0.58%, the stock’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now suggest a more tempered outlook for investors.

Read full news article

Cohance Lifesciences Ltd is Rated Sell

2026-03-20 10:10:45

Cohance Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Cohance Lifesciences Ltd Valuation Shifts Amidst Challenging Market Performance

2026-03-18 08:01:13

Cohance Lifesciences Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade as of early 2026. Despite a modest day gain of 2.63%, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now reflect a more tempered market enthusiasm compared to its historical highs and peer benchmarks within the Pharmaceuticals & Biotechnology sector.

Read full news article

Cohance Lifesciences Ltd Stock Falls to 52-Week Low of Rs.267.85

2026-03-09 13:51:15

Cohance Lifesciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.267.85 today, marking a significant decline amid broader market pressures and company-specific performance issues.

Read full news article

Cohance Lifesciences Ltd is Rated Sell

2026-03-09 10:10:56

Cohance Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Cohance Lifesciences Ltd is Rated Sell

2026-03-08 10:10:38

Cohance Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 09 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Cohance Lifesciences Declines 9.39%: 5 Key Factors Behind the 52-Week Lows

2026-03-07 12:06:04

Key Events This Week

2 Mar: New 52-week low at Rs.298

4 Mar: Further 52-week low at Rs.296.5

5 Mar: Continued decline to Rs.289.35 with valuation upgrade

6 Mar: Week closes at fresh 52-week low Rs.281.25

Read full news article

Cohance Lifesciences Ltd Stock Hits 52-Week Low at Rs.281.25

2026-03-06 10:32:48

Cohance Lifesciences Ltd’s stock touched a fresh 52-week low of Rs.281.25 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial performance and market sentiment.

Read full news article

Cohance Lifesciences Ltd Falls to 52-Week Low Amid Continued Downtrend

2026-03-05 10:20:32

Cohance Lifesciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.289.35 today, marking a significant milestone in its ongoing price decline. The stock has underperformed both its sector and the broader market, reflecting persistent pressures on its financial and operational metrics.